Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Nefiracetam in the Treatment of Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of nefiracetam for Alzheimer's disease has completed. The study was sponsored by the National Institute of Neurologic…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of Acetylcholine on Memory and Attention
This completed clinical trial studied how acetylcholine affects memory and attention. It included participants with Alzheimer's disease and …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Preliminary Study of Fish Oil and Dementia [NA]
A completed preliminary clinical study from Taipei City Psychiatric Center evaluated fish oil (omega-3 fatty acids) for dementia-related out…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Diagnosis and Natural History Study of Patients With Neurological Conditions
An update on a NINDS-sponsored diagnosis and natural history study of patients with neurological conditions, including Alzheimer's disease, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Brain Imaging in Alzheimer's Disease
A completed brain imaging study in Alzheimer disease is reported in this clinical trial update, sponsored by the National Institute of Menta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: Huperzine A in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of huperzine A for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-20Clinical Trial Update: TRx0014 in Patients With Mild or Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update of TRx0014 in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 [Phase 1]
Phase 1 study evaluating SAM-315 for Alzheimer's disease was terminated; the trial assessed safety, tolerability, pharmacokinetics and pharm…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Treatment With Copper in Patients With Mild Alzheimer´s Dementia [Phase 2]
A Phase 2 trial evaluating copper supplementation in patients with mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-05Clinical Trial Update: A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI [NA]
Pfizer-sponsored randomized, placebo-controlled trial evaluated donepezil for mild cognitive impairment, with Alzheimer's disease listed as …
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease [Phase 2]
Phase 2 study evaluating Bryostatin-1 in Alzheimer's disease reports on safety, efficacy, pharmacokinetics, and pharmacodynamics.
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept [Phase 2]
Phase 2 study completed to evaluate the short-term effects of PRX-03140 in patients with mild Alzheimer's disease who were also taking Arice…
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease [Phase 2]
A Phase 2 study assessing the safety, tolerability, and exploratory efficacy of the investigational compound PBT2 in patients with early Alz…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) [Phase 4]
A Phase 4 clinical trial evaluating memantine for cognitive and MRI volumetric measures in moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: The Impact of Lorazepam on Cognition in APOE e4 Carriers [NA]
This completed Mayo Clinic trial examined whether lorazepam affects cognitive function in APOE e4 carriers with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Study Evaluating the Effect of Lecozotan SR on the QTc Interval [Phase 1]
A Phase 1 clinical trial evaluating the effect of Lecozotan SR on the QTc interval in individuals with Alzheimer disease and healthy volunte…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial update from Novartis evaluating the effects of current Alzheimer's disease medications on brain chemical levels. Th…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease [Phase 4]
A Phase 4 trial assessed the safety and tolerability of rivastigmine with add-on memantine in patients with probable Alzheimer's disease; th…
-
CLINICAL_TRIALS trial_result · 2007-12-11Clinical Trial Update: Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of SAM-531 in healthy young and elderly subjects; Alzheimer’s di…
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects [Phase 1]
Phase 1 study evaluating SAM-531 in healthy subjects to assess safety, tolerability, pharmacokinetics, and pharmacodynamics; the Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects [Phase 1]
Phase 1 study comparing two 5 mg Lecozotan SR tablets versus one 10 mg Lecozotan SR tablet to evaluate pharmacokinetics in healthy subjects.…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Single Ascending Dose Study of SRA-444 in Healthy Subjects [Phase 1]
This document reports the completion of a Phase 1 single ascending dose study of SRA-444 in healthy subjects. The sponsor Wyeth is now a who…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of SAM-315 in healthy adults. Alzheimer disease is lis…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males [Phase 1]
Phase 1 study evaluating SAM-315 in healthy Japanese male volunteers has completed, assessing safety, tolerability, pharmacokinetics, and ph…
-
CLINICAL_TRIALS trial_result · 2007-12-04Clinical Trial Update: The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients [Phase 4]
Phase 4 trial updating the effect of anticholinesterase drugs on sleep in Alzheimer's disease patients, including those with obstructive sle…